These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24717156)

  • 1. Epigenetic modifications as potential therapeutic targets in age-related macular degeneration and diabetic retinopathy.
    Kwa FA; Thrimawithana TR
    Drug Discov Today; 2014 Sep; 19(9):1387-93. PubMed ID: 24717156
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Future Perspectives: Agents on the Horizon.
    Maya JR; Sadiq MA; Agarwal A; Kaiser PK; Stoller GL; Sepah YJ; Nguyen QD
    Dev Ophthalmol; 2016; 55():391-8. PubMed ID: 26501694
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rethinking Nuclear Receptors as Potential Therapeutic Targets for Retinal Diseases.
    Choudhary M; Malek G
    J Biomol Screen; 2016 Dec; 21(10):1007-1018. PubMed ID: 27455994
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic mechanisms in the pathogenesis of diabetic retinopathy.
    Zeng J; Chen B
    Ophthalmologica; 2014; 232(1):1-9. PubMed ID: 24714375
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current drug patenting for retinal diseases: beyond VEGF inhibitors.
    Mucke HA; Mucke PM
    IDrugs; 2010 Jan; 13(1):30-7. PubMed ID: 20024845
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Models of retinal diseases and their applicability in drug discovery.
    Malek G; Busik J; Grant MB; Choudhary M
    Expert Opin Drug Discov; 2018 Apr; 13(4):359-377. PubMed ID: 29382242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting epigenetic modifications as a potential therapeutic option for diabetic retinopathy.
    Kumari N; Karmakar A; Ganesan SK
    J Cell Physiol; 2020 Mar; 235(3):1933-1947. PubMed ID: 31531859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetics in age-related macular degeneration: new discoveries and future perspectives.
    Gemenetzi M; Lotery AJ
    Cell Mol Life Sci; 2020 Mar; 77(5):807-818. PubMed ID: 31897542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug delivery methods for posterior segment disease.
    Hsu J
    Curr Opin Ophthalmol; 2007 May; 18(3):235-9. PubMed ID: 17435432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxidative stress and epigenetics in ocular vascular aging: an updated review.
    Zhao B; Zhu L; Ye M; Lou X; Mou Q; Hu Y; Zhang H; Zhao Y
    Mol Med; 2023 Feb; 29(1):28. PubMed ID: 36849907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenomic signatures in age-related macular degeneration: Focus on their role as disease modifiers and therapeutic targets.
    Caputo V; Strafella C; Termine A; Fabrizio C; Ruffo P; Cusumano A; Giardina E; Ricci F; Cascella R
    Eur J Ophthalmol; 2021 Nov; 31(6):2856-2867. PubMed ID: 34798695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation plays important roles in retinal development and diseases.
    Wu J; Liu LL; Cao M; Hu A; Hu D; Luo Y; Wang H; Zhong JN
    Exp Eye Res; 2021 Oct; 211():108733. PubMed ID: 34418429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential drug interventions for diabetic retinopathy.
    Shen Q; Wu JZ; Wong JC
    Drug Discov Today; 2013 Dec; 18(23-24):1334-41. PubMed ID: 24012972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [New drug VEGF Trap-Eye--Eylea--and its use in the treatment of age-related macular degeneration, central retinal vein occlusion, diabetic macular edema, and choroidal neovascularization secondary to pathologic myopia].
    Rejdak R; Szkaradek M; Taslaq W; Kałuzny JJ; Grieb P; Jünemann AG
    Klin Oczna; 2012; 114(4):308-10. PubMed ID: 23461161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diabetic retinopathy and age-related macular degeneration in the U.S.
    Gibson DM
    Am J Prev Med; 2012 Jul; 43(1):48-54. PubMed ID: 22704745
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential of epigenetic mechanisms in AMD pathology.
    Blasiak J; Salminen A; Kaarniranta K
    Front Biosci (Schol Ed); 2013 Jan; 5(2):412-25. PubMed ID: 23277059
    [TBL] [Abstract][Full Text] [Related]  

  • 17. AAV-Based Strategies for Treatment of Retinal and Choroidal Vascular Diseases: Advances in Age-Related Macular Degeneration and Diabetic Retinopathy Therapies.
    Castro BFM; Steel JC; Layton CJ
    BioDrugs; 2024 Jan; 38(1):73-93. PubMed ID: 37878215
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Contribution of epigenetics in diabetic retinopathy.
    Kowluru RA; Mishra M
    Sci China Life Sci; 2015 Jun; 58(6):556-63. PubMed ID: 26025281
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of age-related macular degeneration and therapeutic opportunities.
    van Lookeren Campagne M; LeCouter J; Yaspan BL; Ye W
    J Pathol; 2014 Jan; 232(2):151-64. PubMed ID: 24105633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Current and emerging therapies for ocular neovascularisation.
    Reynolds AL; Kent D; Kennedy BN
    Adv Exp Med Biol; 2014; 801():797-804. PubMed ID: 24664773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.